Authors:
Marra, G
D'Atri, S
Corti, C
Bonmassar, L
Cattaruzza, MS
Schweizer, P
Heinimann, K
Bartosova, Z
Nystrom-Lahti, M
Jiricny, J
Citation: G. Marra et al., Tolerance of human MSH2(+/-) lymphoblastoid cells to the methylating agenttemozolomide, P NAS US, 98(13), 2001, pp. 7164-7169
Authors:
Heinimann, K
Thompson, A
Locher, A
Furlanetto, T
Bader, E
Wolf, A
Meier, R
Walter, K
Bauerfeind, P
Marra, G
Muller, H
Foernzler, D
Dobbie, Z
Citation: K. Heinimann et al., Nontruncating APC germ-line mutations and mismatch repair deficiency play a minor role in APC mutation-negative polyposis, CANCER RES, 61(20), 2001, pp. 7616-7622
Citation: H. Muller et al., Identification and genetic counselling of subjects with a predisposition to HNPCC (hereditary non-polyposis colorectal cancer): old and new research goals, SCHW MED WO, 129(50), 1999, pp. 1978-1985
Authors:
Heinimann, K
Kunz, C
Farine, E
Rey, JP
Muller, H
Dobbie, Z
Citation: K. Heinimann et al., Early diagnosis of familial adenomatous polyposis based on multiple osteomas of the skull, SCHW MED WO, 129(17), 1999, pp. 665-669
Authors:
Heinimann, K
Scott, RJ
Chappuis, P
Weber, W
Muller, H
Dobbie, Z
Hutter, P
Citation: K. Heinimann et al., N-acetyltransferase 2 influences cancer prevalence in hMLH1/hMSH2 mutationcarriers, CANCER RES, 59(13), 1999, pp. 3038-3040
Authors:
Heinimann, K
Scott, RJ
Buerstedde, JM
Weber, W
Siebold, K
Attenhofer, M
Muller, H
Dobbie, Z
Citation: K. Heinimann et al., Influence of selection criteria on mutation detection in patients with hereditary nonpolyposis colorectal cancer, CANCER, 85(12), 1999, pp. 2512-2518